Annual Total Expenses
$274.40 M
+$114.14 M+71.22%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual total expenses is $274.40 million, with the most recent change of +$114.14 million (+71.22%) on December 31, 2023.
- During the last 3 years, IRWD annual total expenses has risen by +$43.20 million (+18.68%).
- IRWD annual total expenses is now -24.11% below its all-time high of $361.60 million, reached on December 31, 2018.
Performance
IRWD Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$65.94 M
-$1.41 M-2.10%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly total expenses is $65.94 million, with the most recent change of -$1.41 million (-2.10%) on September 30, 2024.
- Over the past year, IRWD quarterly total expenses has stayed the same.
- IRWD quarterly total expenses is now -38.27% below its all-time high of $106.82 million, reached on September 30, 2017.
Performance
IRWD Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
IRWD Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.2% | 0.0% |
| 3 y3 years | +18.7% | +8.9% |
| 5 y5 years | -24.1% | +8.9% |
IRWD Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.2% | -24.3% | +69.8% |
| 5 y | 5-year | -11.9% | +71.2% | -24.3% | +70.6% |
| alltime | all time | -24.1% | +303.1% | -38.3% | +202.8% |
Ironwood Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.94 M(-2.1%) |
| Jun 2024 | - | $67.35 M(+6.2%) |
| Mar 2024 | - | $63.42 M(-14.7%) |
| Dec 2023 | $274.40 M(+71.2%) | $74.34 M(+7.7%) |
| Sep 2023 | - | $69.03 M(-20.7%) |
| Jun 2023 | - | $87.06 M(+98.0%) |
| Mar 2023 | - | $43.96 M(+13.2%) |
| Dec 2022 | $160.26 M(-11.7%) | $38.84 M(-3.3%) |
| Sep 2022 | - | $40.16 M(-3.4%) |
| Jun 2022 | - | $41.58 M(+4.8%) |
| Mar 2022 | - | $39.68 M(-34.4%) |
| Dec 2021 | $181.54 M(-21.5%) | $60.54 M(+56.6%) |
| Sep 2021 | - | $38.65 M(-1.4%) |
| Jun 2021 | - | $39.22 M(-9.1%) |
| Mar 2021 | - | $43.14 M(-15.7%) |
| Dec 2020 | $231.20 M(-25.7%) | $51.15 M(-9.7%) |
| Sep 2020 | - | $56.62 M(-0.2%) |
| Jun 2020 | - | $56.72 M(-15.0%) |
| Mar 2020 | - | $66.72 M(-13.1%) |
| Dec 2019 | $311.37 M(-13.9%) | $76.74 M(+11.3%) |
| Sep 2019 | - | $68.98 M(-17.2%) |
| Jun 2019 | - | $83.32 M(+1.2%) |
| Mar 2019 | - | $82.34 M(-17.8%) |
| Dec 2018 | $361.60 M(+4.9%) | $100.13 M(+17.1%) |
| Sep 2018 | - | $85.47 M(-5.6%) |
| Jun 2018 | - | $90.50 M(-11.4%) |
| Mar 2018 | - | $102.09 M(+110.5%) |
| Dec 2017 | $344.64 M(+9.2%) | $48.51 M(-54.6%) |
| Sep 2017 | - | $106.82 M(+7.8%) |
| Jun 2017 | - | $99.06 M(+9.8%) |
| Mar 2017 | - | $90.26 M(-2.1%) |
| Dec 2016 | $315.62 M | $92.22 M(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $85.73 M(+23.1%) |
| Jun 2016 | - | $69.67 M(+2.4%) |
| Mar 2016 | - | $68.01 M(+15.0%) |
| Dec 2015 | $234.00 M(+3.8%) | $59.13 M(+5.1%) |
| Sep 2015 | - | $56.27 M(-8.7%) |
| Jun 2015 | - | $61.60 M(+8.1%) |
| Mar 2015 | - | $57.00 M(-4.7%) |
| Dec 2014 | $225.51 M(-18.0%) | $59.80 M(+11.4%) |
| Sep 2014 | - | $53.66 M(-13.4%) |
| Jun 2014 | - | $61.96 M(+5.0%) |
| Mar 2014 | - | $58.99 M(+14.0%) |
| Dec 2013 | $274.88 M(+23.3%) | $51.77 M(-15.8%) |
| Sep 2013 | - | $61.48 M(-11.6%) |
| Jun 2013 | - | $69.54 M(-24.5%) |
| Mar 2013 | - | $92.09 M(+29.9%) |
| Dec 2012 | $223.01 M(+68.9%) | $70.88 M(+45.2%) |
| Sep 2012 | - | $48.80 M(-12.0%) |
| Jun 2012 | - | $55.44 M(+15.8%) |
| Mar 2012 | - | $47.88 M(+22.2%) |
| Dec 2011 | $132.01 M(+26.2%) | $39.19 M(+15.8%) |
| Sep 2011 | - | $33.83 M(+12.0%) |
| Jun 2011 | - | $30.21 M(+5.0%) |
| Mar 2011 | - | $28.78 M(-2.7%) |
| Dec 2010 | $104.62 M(+10.0%) | $29.57 M(+17.2%) |
| Sep 2010 | - | $25.22 M(-4.8%) |
| Jun 2010 | - | $26.50 M(+13.6%) |
| Mar 2010 | - | $23.33 M(-21.6%) |
| Dec 2009 | $95.14 M(+21.8%) | $29.77 M(+26.4%) |
| Sep 2009 | - | $23.54 M(-6.5%) |
| Jun 2009 | - | $25.19 M(+5.8%) |
| Mar 2009 | - | $23.80 M(+9.3%) |
| Dec 2008 | $78.14 M(+14.8%) | $21.77 M |
| Dec 2007 | $68.08 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual total expenses year-on-year change?
- What is Ironwood Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly total expenses year-on-year change?
What is Ironwood Pharmaceuticals annual total expenses?
The current annual total expenses of IRWD is $274.40 M
What is the all time high annual total expenses for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual total expenses is $361.60 M
What is Ironwood Pharmaceuticals annual total expenses year-on-year change?
Over the past year, IRWD annual total expenses has changed by +$114.14 M (+71.22%)
What is Ironwood Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of IRWD is $65.94 M
What is the all time high quarterly total expenses for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly total expenses is $106.82 M
What is Ironwood Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, IRWD quarterly total expenses has changed by $0.00 (0.00%)